Alosetron in Irritable Bowel Syndrome: Strategies for its Use in a Common Gastrointestinal Disorder

Author： Lembo A.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.63, Iss.18, 2003-01, pp. : 1895-1905

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alosetron and irritable bowel syndrome

By Mayer Emeran A   Bradesi Sylvie  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. : 2089-2098

Informa Healthcare

Access to resources Recommend Favorite

Reassessing the Benefits and Risks of Alosetron: What is its Place in the Treatment of Irritable Bowel Syndrome?

By Andresen V.  

Drug Safety, Vol. 27, Iss. 5, 2004-01 ,pp. : 283-292

Adis International

Access to resources Recommend Favorite

Tegaserod: A Review of its Use in the Management of Irritable Bowel Syndrome with Constipation in Women

By Wagstaff A.J.   Frampton J.E.   Croom K.F.  

Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. : 1101-1120

Adis International

Access to resources Recommend Favorite

Irritable bowel syndrome takes its toll

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 295, 2001-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

The use of psychotropic drugs in irritable bowel syndrome

By Dekel Roy   Drossman Douglas A   Sperber Ami D  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 3, 2013-03 ,pp. : 329-339

Informa Healthcare

Access to resources Recommend Favorite